Durect corporation to participate in the roth capital partners healthcare event "covid-19 therapeutics in development"

Cupertino, calif., oct. 26, 2020 /prnewswire/ -- durect corporation (nasdaq: drrx) today announced that it will partipate in the roth capital healthcare event, "covid-19 therapeutics in development," taking place on wednesday, october 28, 2020. the roth healthcare and biotechnology team...
DRRX Ratings Summary
DRRX Quant Ranking